Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 56 publications
Editor's Note: Cholinergic Signaling via Muscarinic Receptors Directly and Indirectly Suppresses Pancreatic Tumorigenesis and Cancer Stemness.
Journal: Cancer discovery
Published: June 04, 2026
Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer.
Journal: The New England journal of medicine
Published: June 01, 2026
Amivantamab Monotherapy in Chemorefractory RAS/BRAF Wild-Type Metastatic Colorectal Cancer: Results From OrigAMI-1, an Open-Label, Phase Ib/II Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 21, 2026
Circulating Tumor DNA Monitoring in Peptide Receptor Radionuclide Therapy-Treated Patients With Gastroenteropancreatic Neuroendocrine Tumors.
Journal: JCO precision oncology
Published: April 03, 2026
FOLFOXIRI plus panitumumab for left-sided RAS-wild-type metastatic colorectal cancer.
Journal: The oncologist
Published: November 10, 2025
Phase 2 study of azacitidine plus pembrolizumab as second-line treatment in patients with locally advanced or metastatic pancreatic ductal adenocarcinoma.
Journal: The oncologist
Published: October 13, 2025
Oral Bacterial and Fungal Microbiome and Subsequent Risk for Pancreatic Cancer.
Journal: JAMA oncology
Published: September 18, 2025
Quemliclustat and chemotherapy with or without zimberelimab in metastatic pancreatic adenocarcinoma: a randomized phase 1 trial.
Journal: Nature medicine
Published: July 31, 2025
Efficacy and safety of fruquintinib in refractory metastatic colorectal cancer: a systematic review and meta-analysis.
Journal: Journal of gastrointestinal oncology
Published: May 15, 2025
S2303: phase II/III trial of paclitaxel + ramucirumab ± nivolumab in gastric and esophageal adenocarcinoma (PARAMUNE).
Journal: Future oncology (London, England)
Published: March 28, 2025
Perioperative therapy for resectable and borderline resectable pancreatic adenocarcinoma: an Academic Gastrointestinal Cancer Consortium Study.
Journal: The oncologist
Published: March 19, 2025
Last Updated: 09/26/2026